Introduction to Pharmacology Flashcards

1
Q

High-throughput screening

A

Often, many chemicals are tested simultaneously, via high-throughout screening to find a lead compound through in vitro testing during pre-clinical testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Animal testing

A
  • Tests for toxicity in mice or other mammals.
  • If possible, tests effectiveness against the disease.
  • Patent application usually filed during (or before) this time.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ames test for carcinogenicity [Tests for toxicity]

A

Uses a special bacterial variant to detect DNA mutations from a chemical.
- Mutations cause cancer.
Testing for kidney or liver damage cannot be done in bacteria.
- Use mice, other mammals.
- May still be different in people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Carcinogenicity

A

The ability or tendency of a chemical to induce tumors (benign or malignant), increase their incidence or malignancy, or shorten the time of tumor occurrence when it is inhaled, ingested, dermally applied, or injected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

FDA clinical trials in humans: Phase I

A

Show safety/toxicity, in <100 healthy people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FDA clinical trials in humans: Phase II

A

Test effectiveness/dosing, in ~200 affected patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

FDA clinical trials in humans: Phase III

A

Confirm effectiveness, in >1000 affected patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FDA approval: Phase IV

A

Trials are often required after approval, to follow-up on long-term safety and effectiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FDA approval

A

Allows prescriptions by doctors, made/sold by pharmaceutical company that holds the patent.
- Patent expires 20 years after patent application.
- Allows sale of cheaper “generic” drug by other companies.
- Often only 10 years after FDA approval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

“evergreening”

A

Drug companies use various tactics to extend their patent protection and make more money.
- Developing & marketing minor variations of an older drug.
- Developing & marketing combination drugs.
- Filing additions patents.
- … hiring legions of lawyers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Idiosyncratic or paradoxical effect

A

• Sometimes, a drug may cause a totally unexpected and often opposite effect in a few patients.
- Eg. Benadryl (diphenhydramine) is an antihistamine that commonly causes drowsiness, but occasionally acts as a stimulant.
- benzodiazapines (eg Valium) are prescribed as tranquilizers, but in a few individuals result in anxiety, aggressive tendencies, even convulsions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Off-label uses

A

• drugs may legally be prescribed by physicians fo purposes other than those approved by the FDA.
• Pharmaceutical companies may not legally mark drugs for off-label use.
• >90% of gabapentin (Neurontin, an anti-seizure med) prescriptions are for off-label uses such as schizophrenia & neuropathic pain.
- Pfizer fined $430M in 2004, vs $2.7B sales that year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Teratogens

A

• Some drugs are harmless to patients, but can harm fetal development.
- We don’t usually test drugs on pregnant women.
• Thalidomide (approved
1957 in Germany for morning sickness, not approved in US) caused children born with flipper-like hands/feet.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Teratogenicity: Category A

A

Extensive data on pregnant women shows it to be harmless to fetuses.
- Synthroid (synthetic thyroid hormone)
- Few other egs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Teratogenicity: Category B

A

Available data in humans shows no evidence for birth defects, but the data is insufficient to be conclusive, OR there is little or no data on humans, but animal studies show no evidence for birth defects.
- Example: amoxicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Teratogenicity: Category C (Majority of Drugs)

A

• [FDA requires a lot of data for Category A or B]
• Adverse effects have been demonstrated in animal studies, but there is insufficient data on humans to reach any firm conclusion.
- May be prescribed when the physician feels the potential benefits outweigh the risks.
• Examples: Ibuprofen and naproxen (Aleve) Category C in first two trimesters/D in the third trimester.
- High ibuprofen taken by a pregnant woman can cause closing of the ductus arteriosus in the fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Teratogenicity: Category D

A

Clinical data on humans suggests that the drug increases the risk of birth defects. May be prescribed when the physician feels the potential benefits of the drug outweigh the risk.
- Egs: Diazepam(Valium), Phenytoin (Dilantin, an anticonvulsive), ACE inhibitors.

18
Q

Teratogenicity: Category X

A

Clear evidence of substantial risk of birth defects. These drugs should not be used by women who are pregnant or might become pregnant.
- Eg: Accutane acne medication requires use of birth control by all women taking it who are of child bearing age.

19
Q

Drug Abuse Potential

A

The likelihood that abuse will occur with a particular drug product or substance with CNS activity.

20
Q

DEA: Schedule I

A

-Schedule I is purely illegal, Schedule V has least risk.
- No recognized legal use in the U.S.
- phencyclidine (PCP, angel dust), heroin, GHB [marijuana is in limbo].

21
Q

DEA: Schedule II

A
  • Legal drugs with high potential for abuse.
  • amphetamine (Adderall); methylphenidate(Ritalin);
    oxycodone (sustained release: Oxycontin), methadone, hydrocodone, morphine, cocaine.
22
Q

DEA: Schedule III

A
  • III & IV are both legal via prescription,
    • some limitations on refills, some tracking required.
  • Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
  • Egs. anabolic steroids, codeine + acetaminophen (Tylenol 3),
    [NOT hydrocodone + Tylenol (Vicodin)].
23
Q

DEA: Schedule IV

A

Like Schedule III but less severe.
- Egs. benzodiazapines (Valium etc), Lunesta,
- tramadol (lowest-scheduled opioid).

24
Q

DEA: Schedule V

A

The lowest category (eg. pregabalin/Lyrica).
- Many drugs are not controlled under any schedule at all.

25
Q

Generic names

A

Are created by the inventors/discoverers of a drug, but may be used by anyone.

(Generic names are preferred, especially for drugs whose patents have expired).

26
Q

Trade names

A

• Trade names are exclusive to one company and are extensively marketed.
• Eg. systematic name: N-acetyl-para aminophenol.
- Generic name: acetaminophen.
- Trade name: Tylenol, Anacin 3, Panadol (and others).

27
Q

ac

A

Before meals

28
Q

pc

A

After meals

29
Q

bid

A

Twice daily

30
Q

tid

A

3 times daily

31
Q

qid

A

4 times daily

32
Q

qd

A

Every day

33
Q

hs

A

At bedtime

34
Q

PRN

A

As needed

35
Q

PO

A

By mouth

36
Q

NPO

A

Nothing by mouth

37
Q

SC

A

Subcutaneous

38
Q

IM

A

Intramuscular

39
Q

IV

A

Intravenous

40
Q

OTC

A

Over the counter